Synergistic Saccharide Composition for Vaginal Microflora Balance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for vaginal infections, such as bacterial vaginosis, candidal vaginitis, and trichomonas vaginitis, often disrupt the natural balance of vaginal flora due to broad-spectrum antibiotics, leading to secondary complications and systemic toxicity, necessitating additional treatments to restore beneficial Lactobacilli.
Innovation Solution
A composition comprising a first saccharide and a second saccharide or an organic acid synergistically promotes the growth of Lactobacilli, inhibiting pathogenic bacteria without promoting their growth, thereby maintaining a healthy vaginal microflora balance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If broad-spectrum antibiotics are used to treat vaginal infections, then pathogenic bacteria are eliminated, but beneficial Lactobacilli are also killed disrupting microflora balance
Solution Approach 1:
The patent applies local quality by using a combination of specific carbon sources (pentose and disaccharide) that create a selective environment favoring Lactobacilli growth. This localized nutritional support in the vaginal environment allows beneficial bacteria to thrive and outcompete pathogens without requiring broad-spectrum antibiotics that would kill both beneficial and harmful bacteria.
Solution Approach 2:
The patent changes the chemical parameters of the vaginal environment by introducing specific carbon sources (pentose and disaccharide) that alter the growth conditions. This parameter change creates an environment where Lactobacilli can grow preferentially, restoring microflora balance after antibiotic treatment without needing additional antifungal or probiotic interventions.
2Reliability
If antibiotics are frequently administered to the vagina, then infections are treated, but systemic toxicity occurs through absorption
Solution Approach 1:
The patent extracts the essential function of antibiotic treatment (eliminating pathogens) and replaces it with a non-toxic mechanism: using carbon sources to selectively promote Lactobacilli growth. This removes the harmful side effect of systemic toxicity while maintaining the beneficial effect of infection treatment through competitive exclusion of pathogens by restored beneficial flora.
3Quantity of substance
If a single carbon source is provided to Lactobacilli, then growth is supported, but synergistic growth enhancement is not achieved
Solution Approach 1:
The patent merges two different carbon sources (pentose and disaccharide) to create a synergistic effect that enhances Lactobacilli growth beyond what either carbon source could achieve alone. This combination approach maximizes the productivity of bacterial growth support while maintaining selectivity against pathogenic bacteria.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively stimulates the growth of Lactobacillus spp., particularly Lactobacillus crispatus, while inhibiting pathogens like Gardnerella vaginalis and Candida albicans, enhancing the vaginal microflora balance and reducing infection incidence.
Implementation Method 1
a normal vagina generally contains more than about 104 Lactobacilli per milliliter of vaginal fluid. Under normal conditions, the vagina flora provides a mildly acidic environment that helps guard against the invasion of pathogenic microbes
Data Source
AI summary
The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful in supporting healthy microflora, disclosed herein, generally comprise a therapeutic amount of a first saccharide and a therapeutic amount of a second saccharide or an organic acid. The saccharides may be, for example, a pentose, a disaccharide, a cyclodextrin, a pectic substance or a non-digestible polysaccharide. The organic acid may be, for example, malic acid.